BOBBI KRAUSE: Open Payments
NPI 1699254805 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 41 payments from 14 companies in 2025. Trend: 2023 $1,193 · 2024 $1,244 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $192 |
| Novo Nordisk Inc | 9 | $169 |
| Grifols USA, LLC | 4 | $87 |
| Abbott Laboratories | 3 | $65 |
| Exact Sciences Corporation | 3 | $64 |
| Lilly USA, LLC | 2 | $39 |
| Lundbeck LLC | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: QULIPTA, Prolastin-C Liquid, Ozempic, FREESTYLE LIBRE 3, Cologuard Collection Kit, REXULTI, Wegovy, MOUNJARO.
Industry payments across PA — which companies pay providers there.
